Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Elucidating the Origins of H3.3K27M mutant Diffuse Intrinsic Pontine Glioma Development
FY 2024-25
Summary
This proposal aims to investigate the molecular and cellular mechanisms driving the development of Diffuse Intrinsic Pontine Glioma (DIPG), an agggressive pediatric brain cancer with a median survival of less than 1 year. DIPG is characterized by the H3.3K27M mutation, which results in the loss of the H3K27me3 epigenetic mark, leading to altered gene expression and chromatin instability. Despite the mutation's crticial role in DIPG, the early stages of tumour development and the specific cell populations vulnerable to these alterations are still poorly understood. Current research to elucidate the fact has been limited toin vitro studies, which do not capture the complexities of thein vivo tumour microenvironment.The objective of this study is to track how H3K27M mutations affect neural precursor cells, particularly focusing on their lineage progression during DIPG development. The project will use a Sox2CreER; Rosa26LSL-H3.3K27M/LSL-EFYPtransgenic mouse model to selectively introduce the mutation in Sox2(+) cells, which are key precursors in forebrain and hindbrain development. The mutation will be induced under tamoxifen-mediated recombination and mouse brains will be analyzed at key neural development timepoints. The study will then employ single-cell RNA and ATAC sequencing to analyze the transcriptional and epigenetic changes in mutant cell populations, comparing them with non-mutated controls.This will provide insights into the early cellular events leading to DIPG. Such findings could uncover biomarkers for early diagnosis, treatment targets, and potential therapeutic strategies, rendering this novel perspective to understanding DIPG from its initiation stages rather than focusing on the end-stage tumour a powerful approach to early cancer intervention.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
529865
Name
Javier Margaret
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elucidating the Origins of H3.3K27M mutant Diffuse Intrinsic Pontine Glioma Development
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer Initiation; Cancer Stem Cell; Diffuse Intrinsic Pontine Glioma; H3 K27m; H3k27-Altered; Lineage Tracing; Neural Stem Cell; Oncohistone; Pediatric High-Grade Glioma; Single-Cell Rna Sequencing
Abstract
This proposal aims to investigate the molecular and cellular mechanisms driving the development of Diffuse Intrinsic Pontine Glioma (DIPG), an agggressive pediatric brain cancer with a median survival of less than 1 year. DIPG is characterized by the H3.3K27M mutation, which results in the loss of the H3K27me3 epigenetic mark, leading to altered gene expression and chromatin instability. Despite the mutation's crticial role in DIPG, the early stages of tumour development and the specific cell populations vulnerable to these alterations are still poorly understood. Current research to elucidate the fact has been limited toin vitro studies, which do not capture the complexities of thein vivo tumour microenvironment.The objective of this study is to track how H3K27M mutations affect neural precursor cells, particularly focusing on their lineage progression during DIPG development. The project will use a Sox2CreER; Rosa26LSL-H3.3K27M/LSL-EFYPtransgenic mouse model to selectively introduce the mutation in Sox2(+) cells, which are key precursors in forebrain and hindbrain development. The mutation will be induced under tamoxifen-mediated recombination and mouse brains will be analyzed at key neural development timepoints. The study will then employ single-cell RNA and ATAC sequencing to analyze the transcriptional and epigenetic changes in mutant cell populations, comparing them with non-mutated controls.This will provide insights into the early cellular events leading to DIPG. Such findings could uncover biomarkers for early diagnosis, treatment targets, and potential therapeutic strategies, rendering this novel perspective to understanding DIPG from its initiation stages rather than focusing on the end-stage tumour a powerful approach to early cancer intervention.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Javier, Margaret
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~